Taiichi Machida1, et al.
Abstract
Background—The acetylcholine-activated K+ current (IK,ACh) is a novel candidate for atrial-specific antiarrhythmic therapy. This study investigates the involvement of IK,ACh in atrial fibrillation (AF) using NTC-801, a novel potent and selectiveIK,ACh blocker.
Conclusions—A selective IK,ACh blockade induced by NTC-801 exerted anti-AF effects mediated by atrial-selective ERP prolongation. These findings suggest thatIK,ACh may be important in the development and maintenance of atrial fibrillation.
No comments:
Post a Comment